Targeting Neuroinflammation to Treat Alzheimer's Disease

Area of Science:

• Neuroscience
• Immunology
• Pathology

Background:

• Alzheimer's disease (AD) research traditionally focused on beta-amyloid plaques and neurofibrillary tangles.
• Emerging evidence implicates neuroinflammation, mediated by cerebral innate immune cells, as a critical factor in AD pathogenesis.
• Neurodegenerative proteins act as danger-associated molecular patterns, activating inflammatory pathways.

Purpose of the Study:

• To provide an overview of current understanding of AD-related immune processes.
• To describe the key cellular and molecular players involved in AD neuroinflammation.
• To discuss potential future therapeutic targets for Alzheimer's disease.

Main Methods:

• Review of genetic, pre-clinical, and clinical studies on Alzheimer's disease.
• Analysis of the role of innate immune cells in the brain.
• Examination of inflammatory signaling pathways and mediators in neurodegeneration.

Main Results:

• Neuroinflammation is a significant component of Alzheimer's disease pathology.
• Various proteins released during neurodegeneration trigger inflammatory responses.
• These immune responses can compromise neuronal function and lead to cell death.

Conclusions:

• Neuroinflammation is a crucial area of focus for understanding and treating Alzheimer's disease.
• Identifying and targeting specific immune pathways offers potential therapeutic strategies.
• Further research into AD-related immune processes is essential for developing effective interventions.